chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 07-OCT-2015, the patient was vaccinated with ZOSTAVAX (0.65 ml, Lot#L024997, expiration date: 06-OCT-2016), which was improperly stored for 23 days. The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Pt was given a 3 rd dose.  He only listed 1 previous dose on his form and he presented with a vaccine card that only had one dose on it.  When I was documenting the dose after I had given it i realized that it was in fact his 3rd dose of this vaccine.  I have tried reaching the patient to let him know but I have been unsuccessful so far.  I will continue to try.  As far as I am aware he is not having any side effects at this time
Initially in 1st 7 minutes after vaccination my tongue and lip were getting numb....and the my face started to get number about 20 minutes later, on both sides of face,  and my left and right arms were getting numb too . My belly at 20 to 30 minutes started to feel number, and the my Right Buttocks' muscles was hot, not the left as I sat and waited for side-effects evaluation problems to subside.   I waited 1 Hour instead of 15 minutes after shot since I was not feeling normal due to facial swelling and facial numbness and numbness on the surface skin of my arms and some of legs and feet but still could walk and swallow/drink liquid.  ( I was given a small bottle of water to drink from the nurse at vaccine site to make sure I could swallow water and I could).  I do not take a epi pen for anything then or ever before.   Nurse asked me if I wanted to be seen at ER just to be safe, it was 8pm,  I said no , but would go to ER if it got worse, or if I started to get dizzy or not being able to breath.   I brought my O2 Saturation finger monitor with me to vaccine site and it O2 levels were good and pulse were good, around 98% , and 73 bpm range. At  8pm PST the vaccine clinic closed and so I could not longer sit there and be monitored.. I decided I will go home and then left I shot picture of my face and it was very puffy , but not my throat, when I left clinic and drove home .  At home I took my BP and Pulse and O2 and they all were good..  Today is 4 DAYS LATER.... my tongue is not so number anymore, my face is puffy still but about 50% less so...my breathing is fine my throut  feels like plastic on sides but do not have problems breathing... My fingers are able to type .  I feel a bit high but I do not use drugs just alcohol.  I could walk a hour each day on Saturday and Sunday and not yet today, will soon.
Elevated blood pressure  Dizziness and heaviness in legs Went to Er to be monitored and sleep  Lasted about 6 hours
Red rash on left thigh, left arm and left leg.  Spread to whole body. Back became extremely itchy.  Pt  developed full body blisters
Unable to move left arm without major pain.  Fever and chills all day on the day after the injection.  Treated with Tylenol and fluids.
FATIGUE Narrative: 31 yo female reported skin rash and fatigue that lasted for 1 week after her first dose of covid19 vaccine on 2/10/2021. This event was reported on 3/2/2021 when she got her second dose of vaccine. There was no information regarding if patient sought medical care outside but she did not contact the Facility after the reaction with the first dose.
She says that after she received the second dose, she had pain in her right arm and a golf ball sized swelling popped up at the injection site; She says that after she received the second dose, she had pain in her right arm and a golf ball sized swelling popped up at the injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE PAIN (She says that after she received the second dose, she had pain in her right arm and a golf ball sized swelling popped up at the injection site) and INJECTION SITE SWELLING (She says that after she received the second dose, she had pain in her right arm and a golf ball sized swelling popped up at the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (She says that after she received the second dose, she had pain in her right arm and a golf ball sized swelling popped up at the injection site) and INJECTION SITE SWELLING (She says that after she received the second dose, she had pain in her right arm and a golf ball sized swelling popped up at the injection site). At the time of the report, INJECTION SITE PAIN (She says that after she received the second dose, she had pain in her right arm and a golf ball sized swelling popped up at the injection site) and INJECTION SITE SWELLING (She says that after she received the second dose, she had pain in her right arm and a golf ball sized swelling popped up at the injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. It was reported that over the years the patient had received a mix of the Moderna COVID-19 and Pfizer COVID-19 vaccines. For the Moderna, the patient only had a reaction to the second dose.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-566932 (E2B Linked Report). This case was linked to MOD-2023-746425 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-566932:Same reporter Different patient
Fussy after vaccine, 24 hours later when bathing my daughter I felt a hard lump on her left thigh. I immediately checked her other thigh and there was a larger lump. She cried when I touched them so I believe that she?s in pain. I thought that it would have gone away but as of today April 23rd they?re still rather large.
Patient reported generalized itching, no swelling or difficulty breathing. She took 12.5mg of Benadryl.  She denied calling 911.
This case was reported by a nurse to sales representative and described the occurrence of swelling arm in a 4-year-old female subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline), live attenuated measles, mumps (strain not specified), rubella vaccine (MMR II vaccine), and inactivated poliomyelitis virus vaccine (IPOL) for prophylaxis. The subject's medical history included two days in the neonatal intensive care unit for tachypnea following birth. On 29 August 2006 the subject received 5th dose of Infanrix in the left arm, and unspecified doses of MMR II vaccine and IPOL. The injection sites for the MMR II vaccine and IPOL were not provided. On 31 August 2006, 2 days after vaccination with IPOL, Infanrix and MMR II vaccine, the subject experienced swelling of forearm up to the injection site, injection site redness and injection site warmth. At the time of initial reporting, 04 October 2006, the events had improved. The nurse considered the events were probably related to vaccination with Infanrix, MMR II vaccine and IPOL.
pt recvd vax; devel severe local rxn & redness at inject site; also exp fever & body aches
This case was reported by a consumer via call center representative and described the occurrence of skin blotches in a 64-year-old male patient who received FLUARIX QUADRIVALENT (batch number 4XH59, expiry date 2nd June 2018). Concomitant products included Atorvastatin. On 19th October 2017, the patient received the 1st dose of FLUARIX QUADRIVALENT (intramuscular) .5 ml. On 21st October 2017, 2 days after receiving FLUARIX QUADRIVALENT, the patient experienced skin blotches. On an unknown date, the outcome of the skin blotches was not recovered/not resolved. The reporter considered the skin blotches to be possibly related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The patient received FLUARIX QUADRIVALENT in left arm. The patient developed blotches on his ankles 2 days after receiving the vaccine. Blotches also developed on his thighs the next day. On the date of reporting, some of the blotches were appeared to be clearing up. The patient would consult with his physician to assess further. He had received previous flu vaccines, but did not know if any of them were FLUARIX and he never had a effect like this before. The batch number reported for FLUARIX QUADRIVALENT (UXH59) did not exist and was updated to 4XH59, as per sales database.
Right arm numbness; Right arm numbness and discomfort when raising at shoulder level and above; This is a spontaneous report from a contactable nurse (patient). A 55-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1284), intramuscularly on 07Jan2021 08:15 at right arm, at single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication included omeprazole, potassium gluconate; oenothera biennis oil (EVENING PRIMROSE); ascorbic acid (VIT C); glucosamine; ascorbic acid, biotin, calcium pantothenate, cyanocobalamin, folic acid, nicotinic acid, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride, tocopheryl acetate (MULTIVITAMIN). The patient previously took clarithromycin (MACROBID) and known allergies was Macrobid. The patient was not pregnant at the time of vaccination. The patient experienced right arm numbness and discomfort when raising at shoulder level and above on 12Jan2021. No treatment was received. The outcome of the events was not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.
Client became dizzy and lightheaded immediately after receiving her vaccination. No episode of syncope, shortness of breath or rash noted. She reported not having breakfast prior to coming for vaccine. She was offered water and her dizziness resolved within her 15 minute wait time from receiving her vaccine.
Systemic: Abdominal Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Nausea-Medium, Systemic: Vomiting-Medium, Systemic: Weakness-Medium
Really sick; Nauseas; Couldn't get around the house for a couple of days; Felt real sore; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Really sick), NAUSEA (Nauseas), ASTHENIA (Couldn't get around the house for a couple of days) and PAIN (Felt real sore) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Kidney dysfunction, Diabetes and Blood pressure high.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced ILLNESS (Really sick), NAUSEA (Nauseas), ASTHENIA (Couldn't get around the house for a couple of days) and PAIN (Felt real sore). At the time of the report, ILLNESS (Really sick), NAUSEA (Nauseas), ASTHENIA (Couldn't get around the house for a couple of days) and PAIN (Felt real sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.
Vaccine expired on 01-Apr-2022, kept in refrigerator on 04-Apr-2022 and administered on 12-Apr-2022; Received vaccine which expired on 01-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine which expired on 01-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, kept in refrigerator on 04-Apr-2022 and administered on 12-Apr-2022) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine which expired on 01-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, kept in refrigerator on 04-Apr-2022 and administered on 12-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine which expired on 01-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022, kept in refrigerator on 04-Apr-2022 and administered on 12-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   It was reported that, the pharmacy received vaccine on 23-Feb-2022 and that a pharmacy staff member looked up the expiration date and came up with an expiration date of Jun-2022 however the correct expiration date confirmed was 01-Apr-2022. The vial did not undergo any temperature excursion.  No treatment details were reported.
light menstrual bleeding everyday since last period mid April2021 her; irregular menstrual bleeding; This spontaneous case was reported by a consumer and describes the occurrence of INTERMENSTRUAL BLEEDING (light menstrual bleeding everyday since last period mid April2021 her) and MENSTRUATION IRREGULAR (irregular menstrual bleeding) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A21A and 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa), Drug allergy (Macrobid), Depression since June 2014 and ADHD since February 2015. Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) from 2015 to an unknown date for ADHD, FLUOXETINE from 2014 to an unknown date for Depression.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERMENSTRUAL BLEEDING (light menstrual bleeding everyday since last period mid April2021 her) and MENSTRUATION IRREGULAR (irregular menstrual bleeding). On 30-May-2021, INTERMENSTRUAL BLEEDING (light menstrual bleeding everyday since last period mid April2021 her) and MENSTRUATION IRREGULAR (irregular menstrual bleeding) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered MENSTRUATION IRREGULAR (irregular menstrual bleeding) to have an unknown relationship. No further causality assessment was provided for INTERMENSTRUAL BLEEDING (light menstrual bleeding everyday since last period mid April2021 her).    Treatment information was not provided. The patient had a lab done in 2020 which indicated normal hormonal levels and she was not in menopause. The patient was not aware of any other potential cause contributed to the event. The patient did not experienced a similar event in the past.  Treatment information was unknown.   This case was linked to MOD-2021-103508 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Significant follow up received contains patient's info, vaccination facility info, medical history, allergy, new event, and outcome updated.
Gave shot approximately 10:50 AM (L) Delt Pt left for shift at ER (nurse). She  called at 11:30 approximately. Was experiencing (L) forearm  pain. hives (arm) + plus dizziness. she took 50mg Benadryl.  She took 25 mg few hrs later. RXn resolved after  2 doses. No further issues.
Information has been received from a physician concerning a 55 year old female pt with a history of hairy cell leukemia, and splenectomy who on 7/2/02 (also reported as "third quarter of 2002") was vaccinated with a second dose of pneumococcal vaccine 23 polyvalent (641115/1159L). Concomitant medications at the time of the vaccination were Celebrex, pyridoxine, homeopathic medications (Echinacea). On an unspecified date at the end of January 2003, the pt complained of fever, chills, and nausea. The physician reported the next morning the pt went to the ER and she was admitted to the hospital. Her condition continued to deteriorate progressing to positive blood cultures for pneumococcus, which was rpeorted as Pneumococcal sepsis. The physician also reported the pt experienced a stroke, and disseminated intravascular coagulation (DIC), and she was on the ventilator for a "few" days. Additionally the pt lost all of her fingers to amputation except for her thumbs on both hands. It was noted the pt remained in the acute care hospital for about one month and was then transferred to a rehabilitation hospital. According to the reporter, it was "fairly catastrophic," but now the pt is "much better," and she is undergoing physical therapy. The physician reported that he had seen the pt in his office about one month ago and she is making great progress, she drove herself to the appointment, and despite the stroke, she walks without any mechanical assistance. It was reported that the adverse event abated, and the pt is recovering with sequelae. The physician also mentioned a colleague had described a similar case (WAES0307USA03543), but details were not available. There was no product quality complaint involved. Pneumococcal sepsis, disseminated intravascular coagulation (DIC), stroke, and lost all fingers to amputation were considered to be immediately life-threatening. Pneumococcal sepsis, disseminated intravascular coagulation (DIC), stroke, and lost all fingers to amputation were considered to be disabling. Additional info has been requested. A 15-day follow up report received 10/27/2003 adds no new info.
Influenza vaccine was administered on 9/27/11. Seen in office 9/28/11 with vomiting, fever, appetite loss, cough, increased respiratory effort, poor chest expansion, lethargic, admitted to hospital for dehydration.
I got a shingles vaccine on 4/10/14. I take care of my father in a nursing home, brush teeth, wash hands and face. He developed shingles a week later 4-17-14. Developed in right eye. Father 86 yrs old. Congestive heart failure, diabetic, NPH.
This initial spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions described. The reporter stated that on 04-DEC-2015, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 injection (lot # L014420 with expiration date 23-FEB-2017; dose, route and frequency were not provided). No adverse effects were reported. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. Additional information has been requested.
No adverse events reported. Advised to submit to VAERS due to booster given to bivalent booster. Bivalent booster was not received in pharmacy until 9/7/2022.
Dizziness, fever, chills, blurred vision in left eye. Claims aches and pains only on left side. I advised patient to go to weekend clinic and explain the events.
1 day p/vax pt devel swelling of the face, neck & gums, but not the tongue;the swelling persisted as of 6OCT97;4 days post vax;
Patient ID:      83 y.o.       Admit Date:  8/31/2022     Discharge Date: 9/3/22     Principal Dx/ Final Dx:  Metabolic encephalopathy     Relevant Inpt Dx:  Principal Problem:    Metabolic encephalopathy           HPI:     Hospital Course:    This elderly woman was admitted with acute metabolic encephalopathy.  She tested positive for covid.  She had not tolerated paxlovid and did get 3 days remdesivir here.  Today she is off oxygen and her lungs are clear.  She also had UTI and did get empiric antibiotics.  Urine culture not yet resulted.  Plan for discharge to a HCF and follow up pcp.                     Consults:    IP CONSULT TO SOCIAL WORK           Disposition:  SNF     Discharge Condition:  fair
Muscle aches, Fever at 10 hours after vaccination to 100.5 F, continued throughout weekend. Itchy vesicular lesions presented 6/5/2016. Pt also c/o Nausea and Fatigue.
Information has been received from a certified medical assistant concerning a 22 year old female with no reported medical history or drug allergies who on an unspecified date was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) and on an unspecified date had a negative Rubella titer. The patient's outcome at the time of reporting was unknown. No other information was available. Additional information has been requested.
My hair fell out, I have a tremendous bald spot in the back of my head. Other patches and breakage. Alopecia Areata
sore arm; nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 62 year-old female patient received bnt162b2 (BNT162B2), administration date 27Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "recovering", described as "sore arm"; NAUSEA (non-serious) with onset Mar2021, outcome "recovering", described as "nausea".  Additional information: The reporter stated that the patient received her first does of the Pfizer covid-19 vaccine on 27Mar2021, and experienced a sore arm and nausea afterwards but she was better at the time of the report. The reporter asked the ingredients of the Pfizer COVID-19 vaccine and what are they used for; also asked if the ingredients were shown to be safe; and how effective the vaccine is.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Event occurred on 9/9/2022 approximately 3 days after receiving the Shingrix vaccination. Based on talking with the wife of the deceased.  At around 6pm on 9/9/2022 Patient wend downstairs to move the Dryer back into place.  Chest pain started so he sat down to see if it would go away.  Wife stated typically sitting down would stop the chest pain, however, this time it did not stop.  They called 911 for help and event occurred shortly after being transported by ambulance.
13 year old was give Pediatric Pfizer dose, his third Pfizer Vaccination instead of a flu shot, Afluria.
Swollen Tonsils Narrative: Patient is a 61 year old male who received Moderna Vaccine on 3/15/21. Patient contacted Facility on 3/25/21 reporting swelling/tenderness of right tonsil which started several days following vaccine. He reports symptoms are improving and denies any shortness of breath or difficulty swallowing. Patient denies need for any urgent care visit for further evaluation. No reported history of allergic reactions to vaccines in the past.